香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Shouhui Group Limited 手回集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：2621） 須予披露交易 認購理財產品 認購理財產品 | 認購日期 | ： | 2025年7月30日 | | --- | --- | --- | | 訂約方 | : (i) | 深圳手回，作為認購人 | | | (ii) | 浦發銀行，作為產品托管人及銷售機構 | | | (iii) | 浦銀理財，作為發行人及產品管理人 | | 理財產品名稱 | ： | 浦銀理財日添金1號（公司專屬）理財產品 | | 產品類型 | ： | 固定收益、公募開放式淨值型 | | 產品投資範圍 | ： | 本產品主要投資於： | | | (i) | 指定固定收益資產，包括現金、銀行存款、同業存 款、拆借、回購、貨幣基金等貨幣市場工具；國 | | | | 債、地方政府債、央行票據、同業存單等符合監管 | | | | 要求 ...

Core Viewpoint - The Hong Kong stock market is becoming increasingly active, with a notable rise in IPOs compared to previous years. However, the recent IPO of the internet technology company, Shouhui Group, has faced significant challenges, including a drop in stock price shortly after listing, indicating potential issues with its business model and market reception [2][5]. Company Overview - Shouhui Group is a personal insurance intermediary service provider that utilizes an online platform to offer insurance solutions to policyholders and insurers. The company primarily generates revenue through three main business segments: Niubao 100, Xiaoyusan, and Kachabao, with over 60% of its revenue coming from Niubao 100 [5][9][10]. Market Position - In 2023, the total premium of China's personal insurance market reached RMB 3.8 trillion, with the personal insurance intermediary market totaling RMB 237 billion, accounting for 6.3% of the overall market. Shouhui Group ranked eighth in the domestic personal insurance intermediary market with a market share of 2.9% [6][7]. Financial Performance - Shouhui Group's revenue fluctuated significantly from 2021 to 2024, with reported revenues of RMB 1.548 billion, RMB 806 million, RMB 1.634 billion, and RMB 1.387 billion, respectively. The company experienced net losses in 2021 and 2023, while achieving profitability in 2022 [8][19]. Revenue Breakdown - The revenue contributions from the three business segments are as follows: Niubao 100 contributed 67.6% in 2023, Xiaoyusan contributed 19.5%, and Kachabao contributed 12.9%. Niubao 100 is primarily driven by external traffic from media and licensed brokers [15][14]. Cost Structure - The main costs for Shouhui Group include commissions paid to insurance agents and brokers, channel promotion expenses, and employee salaries. Commissions accounted for 55.8% of total costs in 2024 [20][21]. Marketing Strategy - The company has maintained a high marketing expenditure, with over 40% of sales and marketing costs allocated to advertising and promotions in the past three years. In 2024, the total channel expenses reached RMB 801 million, significantly overshadowing the RMB 51 million spent on research and development [23][21]. Market Challenges - The competitive landscape for Shouhui Group is intense, with competition from other intermediaries, banks, and insurance agencies. The reliance on online traffic for customer acquisition poses challenges, especially in a market that increasingly demands profitability over growth [7][25].

Group 1: Fund Industry Developments - Multiple public funds are actively purchasing newly issued floating-rate funds, indicating strong market interest and support from fund companies [1] - The new floating-rate funds are designed to anchor performance benchmarks, incentivizing fund managers to enhance investment capabilities and research systems [1] - As of June 3, 440 A-share listed companies have announced share buybacks, with 78 companies initiating new buyback plans in May alone [1] Group 2: Wealth Management and Financial Services - The wealth management industry is experiencing a "fee reduction wave," with some products offering management fees as low as 0.01% per year, translating to just 1 yuan for a 10,000 yuan investment [2] - Major banks are adjusting their car loan commission structures, reducing high rebate rates to enhance service quality and market competitiveness [2] Group 3: Pharmaceutical and Biotechnology - Bayer's prostate cancer drug Nubeqa has received FDA approval based on positive results from a Phase 3 trial, showing a 46% reduction in the risk of disease progression or death [3] Group 4: IPO and Market Activity - There has been a significant increase in foreign capital participation in Hong Kong IPOs, with 15 out of 27 companies this year attracting foreign cornerstone investors, compared to only 3 last year [5] - Shenzhen Handback Technology Group's IPO faced challenges, with its stock price dropping nearly 30% from the initial offering price shortly after listing [6][7] Group 5: Corporate Financing and Strategic Moves - China Ping An plans to issue zero-coupon convertible bonds totaling 11.765 billion HKD to support its business development and capital needs [10] - United Optoelectronics intends to acquire 100% of Changyi Optoelectronics through a share issuance, with the final transaction details pending [8] Group 6: Market Performance - The US stock market saw all three major indices rise, with the Dow Jones increasing by 0.51% and Nvidia leading the gains in the tech sector [11]

Group 1 - The core point of the article is that Shenzhen Shouhui Technology Group Co., Ltd. has successfully passed the listing hearing on the Hong Kong Stock Exchange after multiple attempts, but faces significant challenges ahead, including financial losses and market competition [2][9]. - The company issued 24.36 million new shares at a price of HKD 8.08 per share, raising a total of HKD 197 million, but the stock price fell significantly on its debut, closing at HKD 6.61, a drop of 18.19% [2][3]. - The company has experienced substantial financial volatility, with revenues of HKD 8.06 billion in 2022, HKD 16.34 billion in 2023 (a 102.7% increase), and a drop to HKD 13.87 billion in 2024 (a 15.1% decrease) [5][6]. Group 2 - The company has accumulated losses of HKD 4.92 billion over the years 2023 and 2024, with net losses of HKD 3.56 billion in 2023 and HKD 1.36 billion in 2024 [5][6]. - The revenue structure is heavily reliant on insurance transaction commissions, with over 99% of income derived from this source, indicating a vulnerability in its business model [6][7]. - Approximately 60% of the funds raised from the IPO are intended for optimizing the sales network and research and development, highlighting the company's focus on improving operational efficiency [7][8]. Group 3 - The company has faced internal governance issues, including a notable incident in 2020 involving a power struggle among founders, which raises concerns about management stability [8][9]. - The company operates under significant pressure from investor agreements that could lead to substantial financial liabilities if it fails to meet certain milestones [7][8]. - The competitive landscape is challenging, with major players like Ant Group and Tencent exerting pressure on smaller platforms, necessitating strategic adaptations for future growth [9].

（以上内容为金融界基于公开消息，由程序或算法智能生成，不作为投资建议或交易依据。） 资金流向方面，当日主力流入205.748万港元，流出377.468万港元，净流出171.72万港元。 手回集团有限公司是一家中国人身险中介服务提供商,致力于通过数字化人身险交易及服务平台,在线为 保险客户提供保险服务解决方案。公司分销的保险产品(包括与保险公司共同开发的保险产品)由保险公 司承保,公司不承担任何承保风险。根据弗若斯特沙利文的资料,于2023年,按总保费计,中国的人身险市场 规模为人民币3.8万亿元。公司主要与保险中介机构和保险公司内部销售人员竞争。此外,公司亦与其他 市场参与者(包括银行保险渠道及保险兼业代理机构)竞争。根据弗若斯特沙利文的资料,于2023年,中国 人身险中介市场的总保费达至人民币2,370亿元,占中国人身险市场总保费的6.3%。于2023年,以中国人身 险中介市场的总保费计,公司排名第八,市场份额为2.9%。线上中介在中国人身险中介市场中占据主导地 位,并于2023年占中国人身险中介市场总保费的89.1%。根据弗若斯特沙利文的资料,以2023年的长期人 身险的总保费计,公司是中国第二大线上保险 ...

Core Viewpoint - The company, Shouhui Group, officially listed on the Hong Kong Stock Exchange on May 30, 2023, but experienced a significant drop in stock price on its first trading day, closing at HKD 6.61, down 18.19% from the initial offering price of HKD 8.08 [1][4]. Company Overview - Shouhui Group, established in 2015, is a provider of personal insurance intermediary services, primarily generating revenue through commissions from insurance companies for distributing insurance products to policyholders [1][4]. - The company’s main distribution platform is "Xiaoyusan," which has undergone leadership changes, with co-founder Xu Han exiting in 2020 [3]. Financial Performance - The projected revenues for Shouhui Group for 2022, 2023, and 2024 are approximately CNY 806 million, CNY 1.634 billion, and CNY 1.387 billion, respectively. The company reported profits of CNY 131 million in 2022, a loss of CNY 356 million in 2023, and a projected loss of CNY 136 million in 2024 [5]. - Adjusted net profits (non-HKFRS) for the same years are estimated at CNY 75 million, CNY 253 million, and CNY 242 million [5]. Market Position - In the competitive landscape of China's online long-term personal insurance intermediary market, Shouhui Group ranks eighth with a market share of 2.9% based on total premiums in 2023 [5]. - The company faces competition from other insurance intermediaries, internal sales personnel of insurance companies, and bank insurance channels [5]. Fundraising and Utilization - Shouhui Group raised approximately HKD 134 million from its global offering, with 60% allocated to enhancing sales and marketing networks, 20% for improving R&D capabilities, 10% for mergers and acquisitions, and 10% for working capital [4].

Core Viewpoint - Hand Return Group officially listed on the Hong Kong Stock Exchange, marking the third company nurtured by the Futian Jin Ke Dual Park, showcasing the success of the digital finance industry in Futian District [1][2]. Group 1: Industry Development - Since 2019, Futian District has developed the Bay Area International Financial Technology City and the International Financial Technology Ecological Park, creating a 60,000 square meter industrial space and achieving a "dual park linkage" development model [2]. - In just five years, the district has successfully nurtured listed companies such as Wealth Trend (listed on the Sci-Tech Innovation Board, stock code: 688318), Lingxiong Technology (listed on the Hong Kong Stock Exchange, stock code: 2436.HK), and Hand Return Group (listed on the Hong Kong Stock Exchange, stock code: 2621.HK) [2]. - As of 2024, the total valuation of companies in the Futian Jin Ke Dual Park is close to 70 billion yuan, with listed companies valued at 34.403 billion yuan and unlisted companies at 29.943 billion yuan [2]. Group 2: Company Innovation - Hand Return Group is recognized as a benchmark enterprise in the Futian Jin Ke Dual Park, driving transformation in the insurance intermediary industry through technological innovation [5]. - The company has developed a technology empowerment system that covers the entire business process from customer acquisition to claims [5]. - AI technology is utilized to enhance business quality, reducing effective complaint rates to below 1% and shortening the dual recording time for insurance policies to 10-15 minutes with a pass rate of 99.6%, significantly improving customer experience [5]. Group 3: Support Services - The Futian Jin Ke Dual Park provides comprehensive "four connections" precision services to support enterprise growth, including market connection, capital connection, policy connection, and talent connection [6]. - The successful listing of Hand Return Group exemplifies the collaborative innovation between government, enterprises, and parks, highlighting the core capabilities in resource integration and ecological construction within the Futian Jin Ke Dual Park [6].

Group 1 - The core point of the article is that Shenzhen Shouhui Technology Group Co., Ltd. (Shouhui Group) successfully listed on the Hong Kong Stock Exchange after two previous failed attempts, marking a significant milestone for the company [1] - Shouhui Group's global offering consisted of 24.3584 million shares, with 12.1792 million shares allocated for both the Hong Kong public offering and international offering, at a final price of HKD 8.08 per share [1] - The company was founded in 2015 and operates as a life insurance intermediary service provider, primarily generating revenue from commissions paid by insurance companies [1] Group 2 - According to Frost & Sullivan, Shouhui Group ranks eighth in the Chinese life insurance intermediary market with a market share of 2.9%, and it is the second-largest online insurance intermediary in China with a market share of 7.3% based on long-term life insurance premiums in 2023 [2] - Shouhui Group's revenue from 2021 to 2024 was reported as follows: CNY 1.548 billion, CNY 806 million, CNY 1.634 billion, and CNY 1.387 billion, respectively [3] - The company experienced a net loss of CNY 204 million in 2021, a profit of CNY 131 million in 2022, and losses of CNY 356 million and CNY 136 million in 2023 and 2024, respectively, while adjusted net profits were CNY 75 million, CNY 253 million, and CNY 242 million for the same years [3] Group 3 - Shouhui Group's business model consists of three digital platforms: the direct-to-consumer platform "Little Umbrella," the agent-enabled distribution platform "Kacha Insurance," and the B2B distribution platform "Niu Insurance 100" [3] - In 2024, the online direct distribution revenue from "Little Umbrella" was CNY 293 million, accounting for 21.3% of the total insurance transaction service revenue; "Kacha Insurance" generated CNY 220 million, representing 15.9%; and "Niu Insurance 100" contributed CNY 865 million, making up 62.8% of the total [3]

Core Viewpoint - Hand Return Group Limited (referred to as "Hand Return Group") was listed on the Hong Kong Stock Exchange, opening at HKD 7.5 and closing at HKD 6.61, reflecting a decline of 18.19% from its opening price [1]. Summary by Relevant Sections Share Issuance and Capital Structure - The total number of shares issued by Hand Return Group was 24,358,400, with 12,179,200 shares allocated for public offering in Hong Kong and 12,179,200 shares for international offering [2]. - The number of shares outstanding at the time of listing, before the exercise of the over-allotment option, was 226,378,600 [2]. Pricing and Proceeds - The final offer price was set at HKD 8.08, resulting in total proceeds of HKD 196.82 million. After deducting estimated listing expenses of HKD 62.59 million, the net proceeds amounted to HKD 134.22 million [4][5]. Business Overview - Hand Return Group is a Chinese life insurance intermediary service provider, focusing on providing insurance service solutions through its digital transaction and service platforms, including Xiao Yu San, Ka Cha Bao, and Niu Bao 100 [6]. - The funds raised are expected to be utilized over the next 60 months to enhance and optimize the company's sales and marketing network, improve services, boost research and development capabilities, and for selected mergers and acquisitions [6]. Financial Performance - Projected revenues for Hand Return Group are as follows: RMB 806.26 million in 2022, RMB 1.634 billion in 2023, and RMB 1.387 billion in 2024. The net profits (losses) for the same years are projected to be RMB 131 million, -RMB 356 million, and -RMB 136 million respectively [7]. - The operating cash flow for 2022 was -RMB 54.26 million, while it is projected to be RMB 205.07 million in 2023 and RMB 110.1 million in 2024 [8].

Market Overview - The Hang Seng Index closed down 1.2% at 23,289.77 points, with a total turnover of HKD 271.56 billion. The Hang Seng Tech Index fell 2.48% to 5,170.43 points. For the month, the Hang Seng Index rose 5.29% [1] - Current valuations of the Hang Seng Index are considered moderately low, while the Hang Seng Tech Index is at historical lows, indicating high investment value in the Hong Kong stock market [1] Blue Chip Performance - CSPC Pharmaceutical Group (01093) led blue-chip stocks, rising 6.3% to HKD 8.1, contributing 6.53 points to the Hang Seng Index. The company is in discussions for three potential licensing collaborations, with total payments potentially reaching USD 5 billion [2][4] - Other notable blue-chip movements include Li Auto-W (02015) up 3.79%, CK Infrastructure Holdings (01038) up 2.11%, while BYD Electronic (00285) and Tingyi (00322) saw declines of 6.03% and 5.01% respectively [2] Sector Movements - Large tech stocks generally declined, with Alibaba down 3.56% and Tencent down 2.41%. Apple-related stocks also faced significant drops, with Cowell e Holdings (01478) down 6.61% [3][5] - The automotive sector continued its downward trend, with Xpeng Motors-W (09868) down 5.04% and Great Wall Motors (02333) down 3.03%. Price competition in the automotive industry is expected to intensify [6] Pharmaceutical Sector - The pharmaceutical sector saw gains, with China Antibody-B (03681) up 21.31% and other biotech stocks also performing well. The upcoming ASCO conference is expected to boost interest in innovative drugs [3][4] Notable Stock Movements - Dekang Agriculture (02419) reached a new high, rising 14.15% due to leading industry cost advantages [7] - Sany International (00631) reported a revenue increase of 14.6% year-on-year, with a net profit increase of 23.2% [8] - New World Development (00017) saw a 3.9% increase, with contract sales reaching HKD 24.8 billion, exceeding 95% of its annual target [9] - Li Auto-W (02015) reported a revenue of RMB 25.93 billion for Q1 2025, a 1.1% year-on-year increase [10] - Hand Return Group (02621) experienced a significant drop of 18.19% on its first trading day [11]